Vette Pharmaceuticals has developed a new male birth control pill called Levederal. It is a once monthly oral contraceptive that has been approved by the FDA as 100% effective when taken correctly. Levederal offers men a reversible and non-invasive option for birth control with minimal side effects. Vette Pharmaceuticals is seeking $30 million in investments to fund marketing and distribution of Levederal.